Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
25,43 USD | -1,01% | -0,70% | +12,22% |
14/03 | ANIKA THERAPEUTICS, INC. : Barrington Research herhaalt koopadvies | ZM |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Omzet 2024 * | 170 mln. 160 mln. | Omzet 2025 * | 182 mln. 171 mln. | Marktkapitalisatie | 373 mln. 351 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -2 mln. -1,88 mln. | Nettowinst (verlies) 2025 * | 6 mln. 5,64 mln. | EV/omzet 2024 * | 2,19 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,05 x |
K/w-verhouding 2024 * |
-166
x | K/w-verhouding 2025 * |
61,5
x | Werknemers | 357 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,4% |
Recentste transcriptie over Anika Therapeutics, Inc.
1 dag | -1,01% | ||
1 week | -0,70% | ||
Lopende maand | +0,12% | ||
1 maand | +0,63% | ||
3 maanden | +13,27% | ||
6 maanden | +32,10% | ||
Lopend jaar | +12,22% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 10-08-20 |
Anne Nunes
COO | Chief Operating Officer | 55 | 01-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 23-10-18 |
Sheryl Conley
BRD | Director/Board Member | 63 | 28-10-21 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31-08-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.32% | 27 M€ | -7,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 25,43 | -1,01% | 83 322 |
17-04-24 | 25,69 | +0,71% | 53 028 |
16-04-24 | 25,51 | +0,79% | 52 332 |
15-04-24 | 25,31 | +1,24% | 37 432 |
12-04-24 | 25 | -2,38% | 46 055 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,22% | 377 mln. | |
-6,35% | 84,57 mld. | |
+3,95% | 39,93 mld. | |
-26,37% | 27,93 mld. | |
+52,09% | 24,21 mld. | |
-6,59% | 17,17 mld. | |
-32,37% | 13,93 mld. | |
-10,45% | 12,3 mld. | |
-15,88% | 11,84 mld. | |
-2,85% | 7,91 mld. |